{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T02:31:04Z","timestamp":1787711464147,"version":"build-2784847793"},"reference-count":75,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,3]],"date-time":"2021-08-03T00:00:00Z","timestamp":1627948800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006484","name":"Vifor Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["kireports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International Reports"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.ekir.2021.07.032","type":"journal-article","created":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T22:39:31Z","timestamp":1628548771000},"page":"2752-2762","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Iron Deficiency in CKD Without Concomitant Anemia"],"prefix":"10.1016","volume":"6","author":[{"given":"Jay B.","family":"Wish","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan D.","family":"Anker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javed","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleix","family":"Cases","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Austin G.","family":"Stack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iain C.","family":"Macdougall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ekir.2021.07.032_bib1","first-page":"23","article-title":"Cases and observations illustrative of renal disease, accompanied with the secretion of albuminous urine","volume":"25","year":"1836","journal-title":"Med Chir Rev"},{"key":"10.1016\/j.ekir.2021.07.032_bib2","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1681\/ASN.2011111078","article-title":"Mechanisms of anemia in CKD","volume":"23","author":"Babitt","year":"2012","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2021.07.032_bib3","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/sj.ki.5000105","article-title":"Association of anemia with outcomes in men with moderate and severe chronic kidney disease","volume":"69","author":"Kovesdy","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2021.07.032_bib4","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1097\/01.ASN.0000092138.65211.71","article-title":"Association of high serum creatinine and anemia increases the risk of coronary events: results from the prospective community-based atherosclerosis risk in communities (ARIC) study","volume":"14","author":"Jurkovitz","year":"2003","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2021.07.032_bib5","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1046\/j.1523-1755.2003.00109.x","article-title":"Chronic kidney disease, anemia, and incident stroke in a middle-aged, community-based population: the ARIC Study","volume":"64","author":"Abramson","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2021.07.032_bib6","doi-asserted-by":"crossref","first-page":"7692376","DOI":"10.1155\/2020\/7692376","article-title":"The impact of CKD anaemia on patients: incidence, risk factors, and clinical outcomes\u2014a systematic literature review","volume":"2020","author":"Palaka","year":"2020","journal-title":"Int J Nephrol"},{"key":"10.1016\/j.ekir.2021.07.032_bib7","first-page":"279","article-title":"KDIGO clinical practice guideline for anemia in chronic kidney disease","volume":"2","year":"2012","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.ekir.2021.07.032_bib8","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1093\/ckj\/sfz091","article-title":"Anemia and iron deficiency among chronic kidney disease stages 3-5ND patients in the Chronic Kidney Disease Outcomes and Practice Patterns Study: often unmeasured, variably treated","volume":"13","author":"Wong","year":"2019","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.ekir.2021.07.032_bib10","doi-asserted-by":"crossref","first-page":"855","DOI":"10.34067\/KID.0001442020","article-title":"Management of anemia in non-dialysis chronic kidney disease: current recommendations, real-world practice, and patient perspectives","volume":"1","author":"Guedes","year":"2020","journal-title":"Kidney 360"},{"key":"10.1016\/j.ekir.2021.07.032_bib11","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/ejhf.84","article-title":"The additive burden of iron deficiency in the cardiorenal-anaemia axis: scope of a problem and its consequences","volume":"16","author":"Klip","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ekir.2021.07.032_bib12","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2215\/CJN.01670408","article-title":"Iron indices in chronic kidney disease in the National Health and Nutritional Examination Survey 1988-2004","volume":"4","author":"Fishbane","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2021.07.032_bib13","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1097\/01.ASN.0000034200.82278.DC","article-title":"Iron status and hemoglobin level in chronic renal insufficiency","volume":"13","author":"Hsu","year":"2002","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2021.07.032_bib14","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1542\/pir.2018-0134","article-title":"Iron deficiency: implications before anemia","volume":"42","author":"Tong","year":"2021","journal-title":"Pediatr Rev"},{"key":"10.1016\/j.ekir.2021.07.032_bib15","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1161\/CIRCULATIONAHA.118.030099","article-title":"Anemia and iron deficiency in heart failure: current concepts and emerging therapies","volume":"138","author":"Anand","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.ekir.2021.07.032_bib16","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1007\/s00392-020-01631-y","article-title":"Iron deficiency is a common disorder in general population and independently predicts all-cause mortality: results from the Gutenberg Health Study","volume":"109","author":"Schrage","year":"2020","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.ekir.2021.07.032_bib17","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/ejh.12645","article-title":"Non-anaemic iron deficiency - a disease looking for recognition of diagnosis: a systematic review","volume":"96","author":"Pratt","year":"2016","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.ekir.2021.07.032_bib18","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.1161\/CIR.0000000000000509","volume":"136","author":"Yancy","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.ekir.2021.07.032_bib19","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ekir.2021.07.032_bib20","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/ejhf.823","article-title":"Effects of ferric carboxymaltose on hospitalisations and mortality rates in iron-deficient heart failure patients: an individual patient data meta-analysis","volume":"20","author":"Anker","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ekir.2021.07.032_bib21","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1016\/S0140-6736(20)32339-4","article-title":"Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial","volume":"396","author":"Ponikowski","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ekir.2021.07.032_bib22","first-page":"568S","article-title":"Iron biology in immune function, muscle metabolism and neuronal functioning","volume":"131","author":"Beard","year":"2001","journal-title":"J\u00a0Nutr"},{"key":"10.1016\/j.ekir.2021.07.032_bib23","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1159\/000486968","article-title":"Positive iron balance in chronic kidney disease: how much is too much and how to tell?","volume":"47","author":"Wish","year":"2018","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.ekir.2021.07.032_bib24","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1111\/tri.12821","article-title":"Iron deficiency, anemia, and mortality in renal transplant recipients","volume":"29","author":"Eisenga","year":"2016","journal-title":"Transpl Int"},{"key":"10.1016\/j.ekir.2021.07.032_bib25","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.117.004519","article-title":"Definition of iron deficiency based on the gold standard of bone marrow iron staining in heart failure patients","volume":"11","author":"Grote Beverborg","year":"2018","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.ekir.2021.07.032_bib26","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1681\/ASN.2019020213","article-title":"Iron deficiency in chronic kidney disease: updates on pathophysiology, diagnosis, and treatment","volume":"31","author":"Batchelor","year":"2020","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2021.07.032_bib27","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.jacc.2017.12.027","article-title":"The burden of iron deficiency in heart failure: therapeutic approach","volume":"71","author":"Rocha","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ekir.2021.07.032_bib28","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.ahj.2013.01.017","article-title":"Iron deficiency in chronic heart failure: an international pooled analysis","volume":"165","author":"Klip","year":"2013","journal-title":"Am Heart J"},{"key":"10.1016\/j.ekir.2021.07.032_bib29","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1080\/00015385.2017.1351239","article-title":"Impact of iron deficiency on exercise capacity and outcome in heart failure with reduced, mid-range and preserved ejection fraction","volume":"73","author":"Martens","year":"2018","journal-title":"Acta Cardiol"},{"key":"10.1016\/j.ekir.2021.07.032_bib30","doi-asserted-by":"crossref","first-page":"5705","DOI":"10.1021\/bi300752r","article-title":"Mechanisms of mammalian iron homeostasis","volume":"51","author":"Pantopoulos","year":"2012","journal-title":"Biochemistry"},{"key":"10.1016\/j.ekir.2021.07.032_bib31","series-title":"Iron Physiology and Pathophysiology in Humans","first-page":"27","article-title":"Cellular iron physiology","author":"Muckenthaler","year":"2012"},{"key":"10.1016\/j.ekir.2021.07.032_bib32","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1002\/ejhf.1710","article-title":"Rationale and design of the AFFIRM-AHF trial: a randomised, double-blind, placebo-controlled trial comparing the effect of intravenous ferric carboxymaltose on hospitalisations and mortality in iron-deficient patients admitted for acute heart failure","volume":"21","author":"Ponikowski","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ekir.2021.07.032_bib33","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nrcardio.2016.203","article-title":"Expert consensus document: mitochondrial function as a therapeutic target in heart failure","volume":"14","author":"Brown","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.ekir.2021.07.032_bib34","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1002\/ejhf.938","article-title":"Limited contractile reserve contributes to poor peak exercise capacity in iron-deficient heart failure","volume":"20","author":"Martens","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ekir.2021.07.032_bib35","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/ejhf.640","article-title":"Myocardial iron content and mitochondrial function in human heart failure: a direct tissue analysis","volume":"19","author":"Melenovsky","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ekir.2021.07.032_bib36","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.molmed.2019.10.007","article-title":"Regulation of mitochondrial ATP production: Ca2+ signaling and quality control","volume":"26","author":"Boyman","year":"2020","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.ekir.2021.07.032_bib37","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.cardfail.2011.08.003","article-title":"Iron deficiency predicts impaired exercise capacity in patients with systolic chronic heart failure","volume":"17","author":"Jankowska","year":"2011","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.ekir.2021.07.032_bib38","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1093\/eurjhf\/hft083","article-title":"Iron deficiency is a key determinant of health-related quality of life in patients with chronic heart failure regardless of anaemia status","volume":"15","author":"Com\u00edn-Colet","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ekir.2021.07.032_bib39","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ijcard.2014.03.169","article-title":"Iron deficiency and health-related quality of life in chronic heart failure: results from a multicenter European study","volume":"174","author":"Enjuanes","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ekir.2021.07.032_bib40","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/qjmed\/hcu045","article-title":"Transferrin saturation ratio and risk of total and cardiovascular mortality in the general population","volume":"107","author":"Stack","year":"2014","journal-title":"QJM"},{"key":"10.1016\/j.ekir.2021.07.032_bib41","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.kint.2019.04.029","article-title":"An increased mortality risk is associated with abnormal iron status in diabetic and non-diabetic veterans with predialysis chronic kidney disease","volume":"96","author":"Cho","year":"2019","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2021.07.032_bib42","doi-asserted-by":"crossref","first-page":"522","DOI":"10.2215\/CJN.15360920","article-title":"Heart failure hospitalization risk associated with iron status in veterans with CKD","volume":"16","author":"Cho","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2021.07.032_bib43","unstructured":"Guedes MH, Muenz DG, Zee J, et\u00a0al. Lower transferrin saturation (TSAT) index is associated with an anemia-independent risk of increased mortality in non-dialysis (ND) CKD patients. Paper presented at: Kidney Week 2020 Reimagined; October 19\u201325, 2020; virtual."},{"key":"10.1016\/j.ekir.2021.07.032_bib44","author":"Guedes"},{"key":"10.1016\/j.ekir.2021.07.032_bib45","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJM199808273390903","article-title":"The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin","volume":"339","author":"Besarab","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ekir.2021.07.032_bib46","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1056\/NEJMoa065485","article-title":"Correction of anemia with epoetin alfa in chronic kidney disease","volume":"355","author":"Singh","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ekir.2021.07.032_bib47","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1056\/NEJMoa062276","article-title":"Normalization of hemoglobin level in patients with chronic kidney disease and anemia","volume":"355","author":"Dr\u00fceke","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ekir.2021.07.032_bib48","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1056\/NEJMoa0907845","article-title":"A\u00a0trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease","volume":"361","author":"Pfeffer","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ekir.2021.07.032_bib49","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s41100-018-0187-2","article-title":"Lessons from clinical trials with erythropoiesis-stimulating agents (ESAs)","volume":"4","author":"Dr\u00fceke","year":"2018","journal-title":"Ren Replace Ther"},{"key":"10.1016\/j.ekir.2021.07.032_bib50","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1159\/000493551","article-title":"Randomized trial comparing proactive, high-dose versus reactive, low-dose intravenous iron supplementation in hemodialysis (PIVOTAL): study design and baseline data","volume":"48","author":"Macdougall","year":"2018","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.ekir.2021.07.032_bib51","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1056\/NEJMoa1810742","article-title":"Intravenous iron in patients undergoing maintenance hemodialysis [published correction appears in N Engl J Med. 2019;380:502]","volume":"380","author":"Macdougall","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ekir.2021.07.032_bib52","unstructured":"Oliveira B, Barakat M, Robertson M, et\u00a0al. Prognostic significance of erythropoiesis-stimulating agent dose requirements in PIVOTAL and its implications for the potential mechanisms of IV iron benefit in maintenance haemodialysis patients. Paper presented at: UK Kidney Week; October 5\u201315, 2020; virtual."},{"key":"10.1016\/j.ekir.2021.07.032_bib53","first-page":"1617","article-title":"Intravenous iron replacement therapy improves cardiovascular outcomes in hemodialysis patients","volume":"35","author":"Righini","year":"2021","journal-title":"In\u00a0Vivo"},{"key":"10.1016\/j.ekir.2021.07.032_bib54","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1056\/NEJMoa1214865","article-title":"Treatment of anemia with darbepoetin alfa in systolic heart failure","volume":"368","author":"Swedberg","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ekir.2021.07.032_bib55","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jacc.2007.09.036","article-title":"Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial","volume":"51","author":"Okonko","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ekir.2021.07.032_bib56","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1056\/NEJMoa0908355","article-title":"Ferric carboxymaltose in patients with heart failure and iron deficiency","volume":"361","author":"Anker","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ekir.2021.07.032_bib57","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/eurheartj\/ehu385","article-title":"Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency","volume":"36","author":"Ponikowski","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ekir.2021.07.032_bib58","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1161\/CIRCULATIONAHA.117.027497","article-title":"Effect of ferric carboxymaltose on exercise capacity in patients with chronic heart failure and iron deficiency","volume":"136","author":"van Veldhuisen","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.ekir.2021.07.032_bib59","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1001\/jama.2017.5427","article-title":"Effect of oral iron repletion on exercise capacity in patients with heart failure with reduced ejection fraction and iron deficiency: the IRONOUT HF randomized clinical trial [published correction appears in JAMA. 2017;317:2453]","volume":"317","author":"Lewis","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.ekir.2021.07.032_bib60","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/ejhf.2092","article-title":"Oral sucrosomial iron improves exercise capacity and quality of life in heart failure with reduced ejection fraction and iron deficiency: a non-randomized, open-label, proof-of-concept study","volume":"23","author":"Karavidas","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ekir.2021.07.032_bib61","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/s00392-020-01633-w","article-title":"Therapeutic approaches in heart failure with preserved ejection fraction: past, present, and future","volume":"109","author":"Wintrich","year":"2020","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.ekir.2021.07.032_bib62","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1002\/ejhf.473","article-title":"Effects of intravenous iron therapy in iron-deficient patients with systolic heart failure: a meta-analysis of randomized controlled trials","volume":"18","author":"Jankowska","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ekir.2021.07.032_bib63","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ejim.2020.04.031","article-title":"Use of intravenous iron in patients with iron deficiency and chronic heart failure: real-world evidence","volume":"80","author":"Gonzalez-Costello","year":"2020","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ekir.2021.07.032_bib64","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.amjcard.2020.11.025","article-title":"A\u00a0meta-analysis of intravenous iron therapy for patients with iron deficiency and heart failure","volume":"141","author":"Osman","year":"2021","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ekir.2021.07.032_bib65","article-title":"Noninvasive imaging estimation of myocardial iron repletion following administration of intravenous iron: the Myocardial-IRON Trial","volume":"9","author":"N\u00fa\u00f1ez","year":"2020","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.ekir.2021.07.032_bib66","doi-asserted-by":"crossref","first-page":"4222","DOI":"10.1002\/ehf2.13053","article-title":"Short-term changes in left and right systolic function following ferric carboxymaltose: a substudy of the Myocardial-IRON trial","volume":"7","author":"Santas","year":"2020","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.ekir.2021.07.032_bib67","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1002\/ejhf.1154","article-title":"Iron deficiency impairs contractility of human cardiomyocytes through decreased mitochondrial function","volume":"20","author":"Hoes","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ekir.2021.07.032_bib68","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1161\/CIRCULATIONAHA.118.038516","article-title":"Effect of iron isomaltoside on skeletal muscle energetics in patients with chronic heart failure and iron deficiency","volume":"139","author":"Charles-Edwards","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.ekir.2021.07.032_bib69","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/ejhf.229","article-title":"The impact of intravenous ferric carboxymaltose on renal function: an analysis of the FAIR-HF study","volume":"17","author":"Ponikowski","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ekir.2021.07.032_bib70","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1001\/jama.2015.15572","article-title":"Comparative risk of anaphylactic reactions associated with intravenous iron products","volume":"314","author":"Wang","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.ekir.2021.07.032_bib71","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.mayocp.2014.10.007","article-title":"The safety of intravenous iron preparations: systematic review and meta-analysis","volume":"90","author":"Avni","year":"2015","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.ekir.2021.07.032_bib72","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.xkme.2020.01.006","article-title":"Iron administration, infection, and anemia management in CKD: untangling the effects of intravenous iron therapy on immunity and infection risk","volume":"2","author":"Ganz","year":"2020","journal-title":"Kidney Med"},{"key":"10.1016\/j.ekir.2021.07.032_bib73","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1681\/ASN.2019090972","article-title":"Intravenous iron dosing and infection risk in patients on hemodialysis: a prespecified secondary analysis of the PIVOTAL Trial","volume":"31","author":"Macdougall","year":"2020","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2021.07.032_bib74","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1080\/14740338.2021.1912010","article-title":"Newer formulations of intravenous iron: a review of their chemistry and key safety aspects - hypersensitivity, hypophosphatemia, and cardiovascular safety","volume":"20","author":"Blumenstein","year":"2021","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.ekir.2021.07.032_bib75","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1080\/07853890.2020.1867323","article-title":"Questions and answers on iron deficiency treatment selection and the use of intravenous iron in routine clinical practice","volume":"53","author":"Richards","year":"2021","journal-title":"Ann Med"},{"key":"10.1016\/j.ekir.2021.07.032_bib76","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1038\/s41598-020-79254-6","article-title":"A\u00a0real-world longitudinal study of anemia management in non-dialysis-dependent chronic kidney disease patients: a multinational analysis of CKDopps","volume":"11","author":"Lopes","year":"2021","journal-title":"Sci Rep"}],"container-title":["Kidney International Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024921013619?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024921013619?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T03:37:51Z","timestamp":1762832271000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468024921013619"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":75,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S2468024921013619"],"URL":"https:\/\/doi.org\/10.1016\/j.ekir.2021.07.032","relation":{},"ISSN":["2468-0249"],"issn-type":[{"value":"2468-0249","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Iron Deficiency in CKD Without Concomitant Anemia","name":"articletitle","label":"Article Title"},{"value":"Kidney International Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ekir.2021.07.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}